NR4A1 and breast cancer: Estrogen and Progesterone Receptor Status: Postmenopausal women with hormone receptor-positive (ER+ and/or PR+) breast cancer are at a higher risk of late recurrence, even up to 10-15 years after initial diagnosis (37).